Results at 43 months' follow-up of a doubleblind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder
Title:
Results at 43 months' follow-up of a doubleblind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder
Author:
Portillo, Jose Martin, Bernardo Hernandez, Rafael Correas, Miguel Gutierrez, Jose Del Valle, Jose Roca, Antonio Vega, Antonio Villanueva, Antonio Gutierrez, Ricardo